A detailed history of Twin Lakes Capital Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 1,772 shares of MRNA stock, worth $96,822. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,772
Previous 1,772 -0.0%
Holding current value
$96,822
Previous $188,000 11.7%
% of portfolio
0.15%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 21, 2022

BUY
$118.07 - $194.18 $209,220 - $344,086
1,772 New
1,772 $210,000
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $207,554 - $312,917
-1,772 Closed
0 $0
Q3 2021

Nov 01, 2021

SELL
$221.9 - $484.47 $112,281 - $245,141
-506 Reduced 22.21%
1,772 $682,000
Q1 2021

May 18, 2021

SELL
$109.18 - $185.98 $32,426 - $55,236
-297 Reduced 11.53%
2,278 $298,000
Q4 2020

Feb 26, 2021

BUY
$65.74 - $169.86 $169,280 - $437,389
2,575 New
2,575 $269,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $21.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Twin Lakes Capital Management, LLC Portfolio

Follow Twin Lakes Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Lakes Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Lakes Capital Management, LLC with notifications on news.